SPY330.06+1.27 0.39%
DIA268.41+1.69 0.63%
IXIC10,941.17+38.37 0.35%

Guggenheim Downgrades AnaptysBio to Neutral

Guggenheim downgrades AnaptysBio (NASDAQ:ANAB) from Buy to Neutral.

Benzinga · -

Guggenheim downgrades AnaptysBio (NASDAQ:ANAB) from Buy to Neutral.